{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:58:51Z","timestamp":1779116331412,"version":"3.51.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T00:00:00Z","timestamp":1554422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00650","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T04:42:59Z","timestamp":1554439379000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Tumor-Associated Disialylated Glycosphingolipid Antigen-Revealing Antibodies Found in Melanoma Patients' Immunoglobulin Repertoire Suggest a Two-Direction Regulation Mechanism Between Immune B Cells and the Tumor"],"prefix":"10.3389","volume":"10","author":[{"given":"Beatrix","family":"Kotlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szabolcs","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara","family":"Eles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanda K.","family":"Plotar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyorgy","family":"Naszados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Czirbesz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miri","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozsef","family":"Tovari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andras","family":"Szekacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Godeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miklos","family":"Kasler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Liszkay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1479-5876-9-214","article-title":"Defining the critical hurdles in cancer immunotherapy","volume":"9","author":"Fox","year":"2011","journal-title":"J. Translat. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1182\/blood-2011-01-325266","article-title":"Autoimmunity associated with immunotherapy of cancer","volume":"118","author":"Amos","year":"2011","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: a prognostic factor that should not be ignored","volume":"29","author":"Pages","year":"2010","journal-title":"Oncogene."},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0165-2478(98)00098-4","article-title":"Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma","volume":"65","author":"Kotlan","year":"1999","journal-title":"Immunol Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","article-title":"CD20+ B cells: the other tumor-infiltrating lymphocytes","volume":"185","author":"Nelson","year":"2010","journal-title":"J. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.seminoncol.2015.05.005","article-title":"Adoptive cell therapy \u2013 tumor-infiltrating lymphocytes, T-cell receptors, and chimeric antigen receptors","volume":"42","author":"Feldman","year":"2015","journal-title":"Semin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1155\/2000\/734293","article-title":"A scFv phage display mini library generated from the immunoglobulin repertoire of breast medullary carcinoma infiltrating B lymphocytes","volume":"16","author":"Kotlan","year":"2000","journal-title":"Dis Markers"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.4049\/jimmunol.175.4.2278","article-title":"Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes","volume":"175","author":"Kotlan","year":"2005","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00262-001-0234-6","article-title":"Immunoglobulin genes expressed by B lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection","volume":"50","author":"O'Brien","year":"2001","journal-title":"Cancer Immunol Immonther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1472-6750-7-70","article-title":"Tumor infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells","volume":"7","author":"Pavoni","year":"2007","journal-title":"BMC Biotechnol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01533513","article-title":"Anti tumor antibody produced by human tumor infiltrating and peripheral blood B lymphocytes","volume":"38","author":"Punt","year":"1994","journal-title":"Cancer Immunol Immunother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fimmu.2018.00470","article-title":"New insights into tumor-infiltrating B lymphocytes in breast cancer: Clinical impacts and regulatory mechanisms","volume":"9","author":"Shen","year":"2018","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10147-008-0809-8","article-title":"Glycosilation in bladder cancer","volume":"13","author":"Ohyama","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"B15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0065-230X(08)60215-8","article-title":"Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens","volume":"52","author":"Hakomori","year":"1989","journal-title":"Adv Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/eji.1830210419","article-title":"Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes","volume":"21","author":"Marks","year":"1991","journal-title":"Eur J Immunol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1385\/1-59259-283-X:281","article-title":"Generation of ScFv from tumor infiltrating B cells from phage display mini-libraries","volume-title":"Methods in Molecular BiologyRT-PCR Protocols.","author":"Gruel","year":"2002"},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4757-0905-6_31","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp Ser"},{"key":"B19","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1093\/nar\/25.24.4876","article-title":"The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools","volume":"24","author":"Thompson","year":"1997","journal-title":"Nucl Acids Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/bioinformatics\/12.4.357","article-title":"TreeView: n application to display phylogenetic trees on personal computers","volume":"12","author":"Page","year":"1996","journal-title":"Comput Appl Biosci."},{"key":"B21","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1093\/nar\/19.15.4133","article-title":"Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains","volume":"19","author":"Hoogenboom","year":"1991","journal-title":"Nucl Acids Res."},{"key":"B22","first-page":"64","article-title":"Genetic information from tumor-infiltrating B lymphocytes as a driver tool (\u201cGPS\u201d) for anti-tumor T cell CARs","volume":"60","author":"Kotlan","year":"2016","journal-title":"Hungarian Oncol. (Magyar Onkol.)."},{"key":"B23","first-page":"1337","article-title":"De-N-acetyl-gangliosides in humans: unusual subcellular distribution of a novel tumor antigen","volume":"59","author":"Chammas","year":"1999","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/1097-0142(20000615)88:12<2693::AID-CNCR7>3.0.CO;2-3","article-title":"Analysis of therapeutic and immunologic effects of R24 anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma","volume":"88","author":"Kirkwood","year":"2000","journal-title":"Cancer."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0206881","DOI":"10.1371\/journal.pone.0206881","article-title":"Differential roles of gangliosides in malignant properties of melanomas","volume":"13","author":"Ohmi","year":"2018","journal-title":"PLoS ONE."},{"key":"B26","first-page":"3808","article-title":"Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides","volume":"43","author":"Ladisch","year":"1983","journal-title":"Cancer Res."},{"key":"B27","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood.V84.4.1193.1193","article-title":"Differential effects of gangliosides on Ig production and proliferation by human B cells","volume":"84","author":"Kimata","year":"1994","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1172\/JCI111631","article-title":"Modulation of the immune response by gangliosides","volume":"74","author":"Ladisch","year":"1984","journal-title":"in vitro. J Clin Invest."},{"key":"B29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-4615-1267-7_24","article-title":"Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines","volume":"491","author":"Hakomori","year":"2001","journal-title":"Adv Exp Med Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/labinvest.3700656","article-title":"Diversity in cell surface sialic acid presentations: implications for biology and disease","volume":"87","author":"Varki","year":"2007","journal-title":"Lab Invest."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12026-014-8600-6","article-title":"The novel panel assay to define tumor associated antibodies in patients with metastatic melanomas may have diagnostic value","volume":"61","author":"Kotlan","year":"2015","journal-title":"Immunol Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.4049\/jimmunol.1201256","article-title":"Ganglioside inhibition of CD8+ T cell cytotoxicity: interference with lytic granule trafficking and exocytosis","volume":"189","author":"Lee","year":"2012","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0014-5793(02)03479-8","article-title":"Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy","volume":"531","author":"Hakomori","year":"2002","journal-title":"FEBS Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/14796694.3.2.201","article-title":"Glycoimmunomics of human cancer: current concepts and future perspectives","volume":"3","author":"Ravindranath","year":"2007","journal-title":"Rev Future Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sbi.2009.06.003","article-title":"Sialic acids as regulators of molecular and cellular interactions","volume":"19","author":"Schauer","year":"2009","journal-title":"Curr Opin Struct Biol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4049\/jimmunol.145.3.891","article-title":"Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside","volume":"145","author":"Chapman","year":"1990","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fonc.2012.00170","article-title":"Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry","volume":"2","author":"Vazquez","year":"2012","journal-title":"Front Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imbio.2005.02.002","article-title":"Generation of anti-Neu-glycolyl-ganglioside antibodies by immunization with an anti- idiotype monoclonal antibody: a self versus non-self matter","volume":"2010","author":"Hernandez","year":"2005","journal-title":"Immunobiology."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874226200902010001","article-title":"Anti-idiotypic antibodies and \u201ctumor-only\u201d antigens: an update","volume":"2","author":"Alejandro","year":"2009","journal-title":"Open Immunol J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fonc.2012.00158","article-title":"Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements","volume":"2","author":"Ladjemi","year":"2012","journal-title":"Front Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fonc.2012.00196","article-title":"The promise of the anti-idiotype concept","volume":"2","author":"Kieber-Emmons","year":"2012","journal-title":"Front Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fimmu.2017.00409","article-title":"A possible role for idiotype \/ anti-idiotype B-T cell interactions in maintaining immune memory","volume":"8","author":"Seledtsov","year":"2017","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3389\/fimmu.2018.02839","article-title":"Galectin-Glyca interactions as regulators of B cell immunity","volume":"9","author":"Giovannone","year":"2018","journal-title":"Front Immunol."},{"key":"B44","first-page":"7889","article-title":"Evidence for and antigen driven humoral response in medullary ductal breast cancer","volume":"61","author":"Coronella","year":"2001","journal-title":"Cancer Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.4049\/jimmunol.169.5.2701","article-title":"Translocation of an antigen to antigen-driven antibody response elicited by tumor infiltrating B cells","volume":"169","author":"Hansen","year":"2002","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3389\/fimmu.2018.002660","article-title":"Antigen specificity and clinical significance of IgG and IgA autoantibodies produced in situ by tumor-infiltrating B cells in breast cancer","volume":"9","author":"Garaud","year":"2018","journal-title":"Front Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:03:00Z","timestamp":1694779380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,5]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2019.00650"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00650","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,5]]},"article-number":"650"}}